Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.04 USD | -1.82% | -3.54% | +44.82% |
May. 13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
May. 10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.82% | 71.77M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+42.55% | 40.47B | |
-10.02% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- TIL Stock
- News Instil Bio, Inc.
- Instil Bio Says 1-for-20 Reverse Stock Split to Take Effect on Dec. 7